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The role of blood leukocytes and of maerophages and other cells  of the reticulo- 
endothelial  system in the defense of the animal host against virus infection has not 
been  extensively studied or clearly defined.  In general,  two  lines  of evidence have 
been presented.  Some experiments  have  demonstrated  that  exudative macrophages 
and leukocytes of peripheral blood are incapable of destroying vaccinia virus in vitro 
(I, 2). Indeed, it has been shown that vaccinia virus multiplies in vitro in such cells 
(including  those  from  immune  animals)  (3).  The  second  line  of investigation  has 
suggested that leukoeytes and maerophages have the ability in vivo  to enhance the 
virus-inhibiting  capacity  of  specific  immune  serum.  For  example,  Fairbrother  (4) 
noted less deaths after intracerebral injection of rabbits with immune serum-vaceinia 
virus  mixtures  containing  normal  or  immune  peripheral  blood  than  following  the 
injection  of immune  serum-virus mixtures  alone.  Similarly Jamuni  and I-Iolden  (5) 
interpreted  their  experiments in rabbits  to indicate  that  immune serum  containing 
normal and immune leukoeytes or macrophages gave greater protection than immune 
serum alone against intracerebral  injection of herpes simplex virus. Irregular results 
and the small number of animals used in the latter two reports make definitive inter- 
pretation impossible.  Beard and Rous (2) showed that normal macrophages, suspended 
in normal serum,  inhibited  the  development of the  local lesions  induced  by intra- 
cutaneous  injection  of  vaccinia  virus  in  rabbits.  They  felt  that  peripheral  blood 
leukocytes had  no inhibitory effect and  that  immune  macrophages had no greater 
effect than normal macrophages on the development of vaccinia lesions. 1 
Recent  investigations  have  indicated  that  lymphoid  cells  are  sites  of antibody 
production. The relation of macrophages to antibody formation has not been so well 
resolved. Ehrich el al.  (6)  were not able to demonstrate agglutinating antibodies in 
macrophages and the fluorescent antibody "sandwich" technique also failed to reveal 
antibody  in  macrophages  (7).  Yet  cellular  transfer  of peritoneal  exudates,  lymph 
* This investigation was supported by a research grant (G-4125) from the National Micro- 
biological Institute, of the National  Institutes of Health,  Public Health Service. 
1  In a  related  field, it has been demonstrated  that as a  result  of in vilro incubation  of 
lymphosarcoma cells with lymph node cell suspensions (from mice that had previously over- 
come the specific lymphosarcoma)  the lymphosarcoma cells lost their  ability  to proliferate 
in hosts (15). 
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node cell suspensions, etc., has lead to the appearance of circulating antibody (as well 
as  "delayed type" hypersensitivity) in the recipient even though the cells themselves 
contained little demonstrable antibody (8). It is possible that macrophages play a role 
in this cellular mechanism. In immune animals, therefore, specific antibody is probably 
contained  inside  some  of  the  leukocytes  and  the  same  or  other  cells may possess 
another type of antibody-elaborating  mechanism that  is conveniently demonstrated 
by transfer of the cells to other animals. In the intact animal, virus that penetrated 
such  cells might be  inhibited  and  the  immune  leukocytes  and  macrophages  might 
thereby influence the resistance of the host to virus infection. 
The experiments  described in  this paper  indicate  that  mixtures of fibrorna- 
immune serum with fibroma-immune leukocytes and macrophages had  signifi- 
cantly  greater  neutralizing  capacities  for  fibroma  virus  than  immune  serum 
alone. 
Malerials and Methods 
Viruses.--An OA rabbit fibroma virus was used in the form of 20 per cent suspensions  of 
infected rabbit testicle in 50 per cent inactivated normal rabbit serum-saline. Titmted intra- 
cutaneously on the a%domen  of rabbits, pools of virus varied in potency from 10  -4 to 10-  i 
IDa0 (infectious doses 50) per 0.1 ml. inoculum. Semlikiforest ~irus was employed in the form 
of 20 per cent suspensions  of infected mouse brain in 50 per cent inactivated normal rabbit 
serum-saline.  Titrated  intracerebrally in mice, the LD60 was  10-~.6/0.03  ml. inoculum.  A 
PR8 strain of influenza virus was used in the form of infected allantoic fluid. Titrated intrana- 
sally in mice, the LD60 was 10-4.°/0.05  nil. inoculum. 
Animals.--Rabbits:  6 to 7 pound New Zealand white male and female rabbits were used in 
almost all experiments. Occasionally 6 to 7 pound California rabbits of both sexes were also 
employed. Cell suspensions  were always titrated in the homologous breed of rabbits. Mice: 
10 gm. Swiss mice were used for intracerebral titration of Semliki forest virus and for intra- 
nasal administration of PR8. 
Preparalion of Serum.--Blood was obtained by cardiac puncture and allowed to clot. In 
earlier experiments separation was allowed to proceed 30 minutes at 35°C. and then the clot 
was sedimented by centrifuging 20 minutes at 2000 R.P.K. at room temperature. The super- 
natant  serum was centrifuged once again 20  minutes at 2000 mP.M. In later experiments, 
after the blood had clotted, the cells were sedimented by centrifuging twice for 20 minutes at 
2000 ~.P.~.  in a  refrigerated centrifuge maintained  at 2°C. In all instances serum from at 
least 3 rabbits was pooled for use in a test. After centrifugation serum was kept at 4°C. while 
the test was set up. Immune sara. 1.0 mi. amounts of 5 per cent fibroma virus was injected 
intracutaneously on the abdomens of rabbits. At intervals, varying from 1 day to 3 months 
after injection, blood was obtained and serum prepared. 
Preparation of Cell Suspensions.--Peritoneal  exuda~ive cells. (a) Mononuclear exudates were 
prepared by injecting 60 nil. of sterile mineral oil intraperitoneally into rabbits. 6 days later 
500  ml. of isotonic saline containing  100 units  of penicillin, 100 ~g.  of streptomycin,  and 
0.01 mg. of heparin/ml, were introduced into the peritoneum. A trocar set was used to place 
an aspirator  tube in the peritoneum.  The exudative cells were then removed by applying 
suction to the aspirator tube. Mineral oil was allowed to separate in a separatory funnel for 
15 minutes at 4°C. The cells were sedimented in 250 ml. bottles at 1200 R.P.~. for 15 minutes. 
Sedimented cells from at least 3  rabbits  were pooled, washed  once in isotonic saline, and 
centrifuged 5 minutes at 800 R.P.M. The sediment was then washed once in the same serum DAVID  R.  GINDER  45 
in which the cells were to be finally suspended and centrifuged once more in calibrated tubes 
at 800 R.P.M. for 5 minutes. Supernatant was carefully removed with a  capillary pipette and 
ceils were suspended in fresh serum appropriate for use in a given test. Leukocyte and erythro- 
cyte counts were performed with cells diluted 1:10 in serum. Differential counts were made 
by counting 200 cells in smears stained with Wright's stain. Cell viability was determined by 
staining with methylene blue; 0.1 per cent aqueous solution gave more satisfactory results 
than a  1 per cent solution (9). The results of these examinations are listed in Table I. Similar 
studies, performed on the other types of cell suspensions diluted 1:10 in appropriate sera, 
are also listed in Table I. In this paper the large mononuclear cells of peritoneal exudates 
and organ cell suspensions are sometimes arbitrarily referred to as macrophages. All other 
white ceils are called leukocytes. Aerobic and anaerobic cultures of the cells showed no growth. 
(b)  Polymorphonuclear exudates were prepared by administering 500 ml. of isotonic saline 
TABLE  I 
Content of the  Various  Cell Suspensions 
Differential leukocyte count 
Viable  I  E  thro  tea  ry  cy  Cell suspensions  ,eukocytet  leuko-  t* 
~er ram3*  Pol~-  [  Lyre-  Large  cytes  per mm 
m°~n  r°"  phocyte  mononuclear  ,__ 
Mononuclear peritoneal ex-  tkousasds  per cott  per cent  per cent  ,¢r cent  tlwnsands 
udates .................  50--70  4-10  16-30  60-80  95  '  100-800 
Polymorphonuclear  peri-  l 
toneal exudates  .......  60-90  65-95  6--20  I  5-10  95  100-1000 
Buffy coats ..............  18-40  [ 40-45  40-45  4-10  ~--95  400-2000 
(Monocytes) 
Spleen ..................  80-120  5-10  40-50  40-50  t0-50  100-200 
Lymph node .............  160-210  0-1  93-95  5-6  ~0-50  1 
Liver ....................  8-10  5-10  30-40  I  60-70  50:~  50-100 
Kidney  ...................  1-2  0  20-30  70-80  50~/  Not done 
Heart ....................  1-2  15-25  30-50  30-50  50~  Not done 
* Cell counts made after cell sediments were diluted 1:10 in appropnate serum. 
All parenchymal cellular matter stained blue with methylene blue. It was difficult to 
distinguish this material from blue staining leukocytes. 
containing 100 units of penicillin and  100 ttg. of streptomycin/ml, into the peritoneum of 
rabbits 16 hours before the cells were collected. Then, just before harvest, 500 additional ml. 
of isotonic saline containing 100 units penicillin and 100 gg. of streptomycin/ml, and 0.01 nag. 
heparin/ml, were introduced into the peritoneum. Cells were harvested, washed, and pooled 
in the same manner as the mononuclear cells except that separatory funnels were not re- 
quired. Cultures were usually sterile. 
Buffy Coats.--Blood was removed from the heart and delivered into silicone-coated tubes 
containing sufficient heparin to give a final concentration of 0.05 mg./ml. After centrifugation 
at 3000 R.P.M. for 40 minutes, the buffy coat was removed and pooled with buffy coats from 
at least 2 other rabbits and centrifuged again at 3000 R.p.u.  for 40 minutes. A  refrigerated 
centrifuge (2°C.)  was used for these procedures. Finally the sedimented ceils were diluted 1 : 10 
in the serum to be employed in the test. Spleen cdl susp~tsions:  Spleens from at least  3 rab- 
bits were harvested, minced, and forced through a  100 mesh stainless steel sieve into isotonic 
saline with the plunger of a  syringe. The particles were washed in the same manner as peri- 46  RESISTANCE TO  FIBROMA VIRUS INEECTION 
toneal exudates and finally suspended 1:10 in serum. Lymph node celt suspensions: Afillary 
lymph nodes were harvested, freed of fat,  and prepared like splenic cell suspensions. Liver, 
kidney, and heart cell suspensions: 5 to 10 gm. portions of these organs were obtained from 
at least 3 rabbits and were prepared like splenic cell suspensions. 
Neutralization  Tests,--Fibroma: Virus  dilutions  and  constant amounts  of  serum  were 
employed in these tests. Virus dilutions were made in 10 per cent tryptose phosphate broth 
containing 100 units of penicillin and 100 #g. streptomycin/mi, and added to equal amounts 
of serum or serum-cell mixtures to give final dilutions of virus ranging from l0 t to  10  -~.7. 
Initially tests were incubated at 36°C. for 60 to 90 minutes. The tubes were shaken at  15 
minute intervals  during incubation and put in an ice water  bath during  titration.  Non- 
incubated tests, used in the reported experiments, were thoroughly mixed and immediately 
placed in an ice water bath and titrated.  Each tube was thoroughly mixed just before its 
contents were taken for injection. Titration was performed intracutaneousiy on the abdomen 
of rabbits in 0.1 nil. amounts, each dilution being injected into 3 to 6 rabbits using No. 25 
needles and 0.25 ml. syringes. The location of the inocula is discussed further under results. 
The results of the neutralization tests were observed and recorded daily from the 1st to the 
10th day (when lesions had begun to regress) in terms of the relative size of the lesions. At 
the height of the reaction, accurate measurements were made and the outline of the fibromas 
was traced. The volume of the fibromas was calculated by multiplying the depth X ~r radius  s. 
In some tests the relative size of the fibromas was also checked by removing and weighing 
the individual lesions. The living cells that were injected intradermally  into test rabbits 
caused variable reactions depending on the batch of cells, the individual test rabbit, and the 
concentration of the cells injected. In almost all cases, the local lesions caused by the cell 
deposit disappeared before fibroma lesions reached their maximum size. S~mllki forest virus: 
Mouse intracerebral neutralization tests were performed as recommended by the Neurotropic 
Virus Disease Commission (10) except that serum inactivation  and incubation were omitted 
to duplicate the conditions of the fibroma neutralization test. PRS: Mouse intranasal  neutrali- 
zation tests were also set up to correspond to the fibroma tests. 6 mice were inoculated per 
dilution with 0.05 ml. inocula. 
EXPER~N~AL RESULTS 
The Effect  of Adding  Immune  Monon~lear  Exudates  to  Mixtures of Fibro'm~ 
Virus and Fibm~,m~ Immune Serum: 
Living exudative cells from immune rabbits were added  to serum-fibroma 
virus mixtures to determine whether the added cells would enhance the neu- 
tralizing ability of immune serum. ~q[ononuclear peritoneal exudates and sera 
were obtained from normal rabbits and from rabbits that had been infected 
with fibroma virus 9 days previously. Fibroma neutralization tests were set up, 
thoroughly shaken, and placed in an ice water bath and immediately titrated 
in rabbits. The addition of immune cells effected a significant further inhibition 
of fibroma virus as indicated in Tables II and III. Fig. 1, although not taken 
from this particular experiment, illustrates the repeated observation that the 
addition of immune cells significantly decreased the volume of the resulting 
fibromas.  Almost invariably the  lesions that  appeared  where  immune cello 
fibroma mixtures were  injected took  the  form of  doughnut-like lesions also 
seen in Fig. 1. Similar findings were observed in over 20 separate experiments. 47 
Final fibrom& dilutions 
Fibroma 
log ID~ 
lO"x 
6/6* 
6/6 
6/6 
serum ....................................  5/6 
Normal rabbit serum  ........................... 
Fibroma immune serum ...................... 
Normal cells 1:20~ in fibroma immune serum... 
Fibroma immune cells 1:20 in fibroma immune 
10"2  lO--S  1(,-4  10" 4 7 
6/6  6/6  6/616/6 
5/6  4/6  1/6  0/6 
6/6  3/6  0/6  0/6 
0/6  0/610/6t0/6 
4.8 
3.2 
3.0 
1.4 
Rabbit 
* Numerator, No.  of rabbits developing fibromas; denominator, No.  of rabbits injected. 
:~ Final dilution. 
TABLE  111 
Effect of Fibroma Immune Exudative Cells on Neutralization of Fibroma Virus. 
Volumes of Fibroma in Presence of Fibroma Serum and of Fibroma Serum 
Containing Immune Cells 
A  1:20" Immune cells in immune serum 
Immune serum 
B 
C 
D 
E 
Fibroma virus with 
0.5 
1.8 
1:20 Immune ceils in immune serum 
Immune serum 
1:20 Immune cells in mamune serum 
Immune serum 
1:20 Immune cells in unmune serum 
Immune serum 
1:20 Immune cells in Immune serum 
Immune serum 
1: 20 Immune cells in ~mmune serum 
Immune serum 
Volume of fibromas in em.a 
Final fibroma dilutions 
10-1  10 ~  10' 
0 
+ 
0 
0.4 
0.5 
1.9 
0.3 
1.2 
0.1 
0.5 
0.3 
2.3 
0 
0.3 
0 
0 
0 
0.3 
0 
0.2 
0 
0.1 
0 
0.3 
)-4  lO-4a 
0 
0 
0 
O. 
0 
+ 
+ 
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TABLE  II 
Effect of Mononudear  Peritoneal Ex'udates on Neutralization  of Fibroma Virus 
* Final dilution of cells. 
Volume less than 0.1 era. 8 
Standardization  of the Neutralization Test Containing Added Peritoneal Exudates: 
The following tests were performed to standardize the test and to investigate 
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(a)  Effect of Incubation.--As indicated, incubation in dtro was not required 
for demonstration of the fibroma-inhibiting effect of immune peritoneal cells. 
Direct comparison revealed that the effect of a given ~mmune cell suspension 
was not changed by incubation at 36°C. for as long as 90 minutes. Genre but 
thorough shaking of the tubes (in incubated tests)  at various intervals from 
5 to 15 minutes did not in any way modify the effect of the cells. Incubation 
was not employed in the reported experiments. 
(b)  Preparation of Sera.--In the early experiments, sera were prepared by 
incubating the  clot for 30  minutes at 36°C.  before  centrifugation at  room 
temperature. Bemuse the preparation of cell suspensions did not require heating 
at 36°C.  it was possible  that non-specific heat-labile factors present in  the 
added  cells  were  responsible  for  the  increased  inhibition of fibroma virus. 
Investigation revealed  that  the  addition of fresh guinea pig,  commercially 
prepared guinea pig, or fresh rabbit complement did not increase the fibroma- 
neutralizing power of serum separated at 36°C. Similarly, rabbit serum sepa- 
rated from clot by centrifugation in a refrigerated centrifuge (2°C.)  caused no 
greater neutralization of virus than serum separated at 36°C. Although these 
experiments indicated that serum separated at 36°C. was not lacking in labile 
elements, in the later part of the investigation all sera were prepared by the 
cold separation method. All reported experiments have been performed with 
cold-separated sera. 
(c)  Balance of Immune Serum and Infectivity of Virus.--In these experiments 
it was  necessary to  use immune sera  that did not  completely prevent  the 
appearance of virus lesions.  It was empirically determined that rabbits,  in- 
fected 8 to 10 days previously with fibroma virus, furnished serum with neu- 
tralizing qualities optimal for demonstrating the effect of added cells. However, 
the inhibitory effect of immune cells was also demonstrated with cells obtained 
from rabbits that had been infected with fibroma 2 weeks to 3 months be- 
fore use. 
(d)  Spacing of Titrations.--Titrations were originally carried out by making 
injections in 2 or more parallel rows on each side of the midline of the abdomen. 
The rows of inocula were varied from rabbit to rabbit in the 4 or more possible 
positions. It was noted that in addition to the individual rabbit reaction to 
fibroma, fibroma virus caused smaller lesions as the flanks were approached. 
Therefore in later tests (including all the reported tests) mixtures to be com- 
pared were inoculated parallel to each other one on each side of the midline. 
Generally 2 parallel rows were employed per rabbit-one in the upper and the 
other in the lower abdomen. The lower abdomen was not as sensitive an indi- 
cator of fibroma virus as the upper end. Results of tests employing titrations in 
2 parallel rows confirmed all earlier results. 
(e) Effect of Change in pH Induced by Mononuclear Cells.--In tests incubated 
at 36°C.  the addition of living mononuclear cells  (from normal and immune DAVID  R.  GINDER  49 
rabbits) depressed the pH of virus-serum mixtures from 7.8 to 8.1 to 7.1  to 7.4 
(Beckman glass electrode). Other tests indicated that fibroma virus infectivity 
was stable under the conditions of the test over a  pH range of 6.8  to 8.2.  In 
tests maintained in an ice water bath, as were all the reported tests, the addi- 
tion of living cells caused no change in the pH of the test system. 
The Effect of Adding Normal Mononuclear Exudates to Immune Serum-Fibroma 
Virus Mixtures: 
Variable effects were obtained when normal mononuclear peritoneal exudates 
were  added to  immune  serum-virus mixtures.  In  15  of 30  separate tests  the 
addition of these normal  cells did not  increase  the fibroma-inhibifing power 
of the serum. In the other tests slight to moderate increase in fibroma-inhibiting 
power  occurred.  Ordinarily,  the  decrease  in  size  of fibroma  lesions brought 
TABLE  IV 
Inability of Sensitized Normal Peritoneal Exudates to Simulate the Effect of Fibroma Immune 
Exudative Cells 
Fibroma virus with 
Fibroma immune serum ....................... 
Fibroma immune  serum  sensitized  normal cells 
1:20" in fibroma immune serum  .............. 
Normal cells 1 : 20 in fibroma immune serum ..... 
Fibroma immune cells 1:20 in fibroma  immune 
serum  ..................................... 
Final fibroma dilutions 
1o-_~_, 
3/3 
3/3 
3/3 
2/3 
i0-, 
3/3 
3/3 
3/3 
0/3 
10-1 
3/3 
3/3 
3/3 
0/3 
10-*  10-4,7  __ 
0/3  0/3 
0/3  0/3 
0/3  0/3 
0/3  0/3 
Fibroma 
log IDi0 
3.5 
3.5 
3.5 
1.2 
* Final dilution. 
about  by  the  addition of  normal  cells was  slight compared  to  the  effect  of 
immune  cells. In all cases immune  cells caused greater inhibition of fibroma 
virus than  did normal cells. Extensive experiments, not described here, have 
so far failed to disclose the cause of the variable effect of normal mononuclear 
exudates. 
The Effect of Adding Normal Mononuclear Exudates (Sensitized witk Antibody) 
to lmmune Serum-Fibroma  Virus Mixtures: 
Immune peritoneal exudates and sera were obtained from rabbits infected 9 days previously 
with fibroma  virus.  Mononuclear peritoneal exudates from  normal rabbits were washed  in 
saline and then in immune serum. After resuspension in a dilution of 1:10 in immune serum 
the cells were incubated 60 minutes at 36°C. The calls were sedimented and resuspended l: 10 
once again in fresh immune serum.  Serum fibroma virus mixtures with such treated normal 
cells, untreated normal cells, and immune  cells were  tested in one such experiment whose 
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The  results,  confirmed in 3  other  tests,  plainly indicate  that  normal  cells, 
sensitized with immune serum before their use in a  test,  are no more effective 
in  inhibiting  fibroma  virus  than  are  untreated  normal  ceils  suspended  in 
immune serum. Similar results were obtained using normal ceils sensitized for 
30 minutes  at  25°C.  or 36°C.  Control tests  indicated  that immune cells sus- 
pended in immune serum did not lose any of their fibroma-inhibiting capacity 
as the result of incubation  at 25°C.  or 36°C. for as long  as 60 minutes.  The 
effects of those normal cells, that somewhat reduced the size of fibroma lesions, 
were not increased by sensitization of the cells with fibroma antibody prior to 
use in the test proper. 
The Effect of Frozen and Thawed Immune Mononuclear Exudates: 
Short time sensitization of normal mononuclear exudates with immune serum 
did not endow these cells with  the special properties  of immune cells.  It was 
therefore unlikely that the mechanism of action of immune cells was via simple 
transfer of antibody attached to the outside of cells. The following experiment 
demonstrated that the effect of immune cells was not mediated by transfer of a 
greater  total  quantity of preformed antibody than  was contained  in immune 
serum alone. 
Immune mononuclear exudates were diluted 1:10 in immune serum and frozen and thawed. 
Freezing, in one 30 minute or three  10 minute cycles, was accomplished in a dry ice--95 per 
cent alcohol bath. Thawing was performed at 36°C. Immune serum was similarly frozen and 
thawed. 
Cells frozen and thawed by either method failed in 4 separate neutralization 
tests to increase the fibroma-inhibiting power of immune serum. 
Total Fibroma-Inhibiting  Power of Immune Serum Compared to Equal Volumes 
of Immune Cells and of Normal Cells Sensitized  with Immune Serum: 
Experiments  thus  far  described  indicated  that  simple  transfer  of  greater 
amounts of neutralizing antibody was not the mechanism of fibroma inhibition 
by fibroma immune cells, that living cells were required, and that normal cells 
coated  with  immune  serum  did  not  simulate  the  effects  of  immune  cells. 
Further evidence along these lines was supplied by experiments that compared 
the  total  neutralizing  capacity  of  equivalent  volumes  of  immune  cells  and 
immune serum. 
Immune serum and immune peritoneal mononuclear cells were prepared from rabbits that 
had been infected 9 days previously with fibroma virus. Immune cells were washed twice in 
saline or once in saline and once in immune serum before suspension 1:5 in normal rabbit 
serum. Immune serum was also diluted 1: 5 in normal rabbit serum. Preformed antibody was 
measured by comparing serum and cell suspensions after each had been frozen and thawed. 
The total fibroma-inhihiting capacity of the same serum and cell suspensions was measured 
using unfrozen serum and living cells. DAVID R.  GINDER  51 
The results of such an experiment, depicted in Table V,  indicate that the 
antibody present in the immune serum is significantly greater than that con- 
tained (in a preformed state) in a comparable volume of immune cells; however 
the living cells actually inhibit fibroma virus significantly more than an equal 
volume of immune serum. These results were confirmed in 6 additional experi- 
ments using immune cells frozen in a  dry ice-alcohol bath for one 30 minute 
or three 10 minute freezing cycles. 
TABLE  V 
Fibroma Virus Inhibition  by Unmodified and by Frozen and Thawed Immune Calls 
and Immune Serum 
Rabbit 
G 
H 
K 
Fibroma  virus  with 
Frozen and thawed immune 
Frozen and thawed immune 
Frozen and thawed immune 
Frozen and thawed immune 
Frozen and thawed immune 
Frozen and thawed immune 
cells 1:10" in NRS$ 
serum 1  : 10 in NRS 
cells 1:10 in NRS 
serum 1" 10 in NRS 
cells 1:10 in NRS 
serum 1:10 in NRS 
Living immune cells 1:10 in NRS 
Immune serum 1:10 in NRS 
Living immune cells 1  : 10 in NRS 
Immune serum 1:10 in NRS 
Living immune cells 1  : 10 in NRS 
Immune serum 1  : 10 in NRS 
Volume of fibromas  in cm.t 
Final  fibroma  dilutions 
10  -l  lot 
5.7  2.2 
2.8  0.7 
4.6  1.4 
1.2  0.2 
8.3  2.1 
3.2  0.4 
1.4 
2.7 
1.2 
3.2 
2.3 
4.6 
oo.4 
0.2 
+ 
0.5 
+ 
:° 
9  0.2 
:° 
4  0.1 
6  0.2 
10-_._~._* 
2 
+ 
0 
0.3 
+ 
0 
0 
0 
0 
0 
0.I 
10-~.7 
+ 
0 
+ 
0 
+ 
0 
0 
0 
0 
0 
0 
0 
* Final dilution. 
Normal rabbit serum. 
§ Volume less than 0.1 cm.  s 
Normal mononuclear cell exudates were  sensitized by incubating them in 
fibroma-immune serum 60  minutes at 36°C.  The  cells were  sedimented and 
resuspended 1:5  in normal rabbit serum. These sensitized normal cells were 
compared after freezing and thawing and in the living state with appropriately 
treated immune serum diluted 1 : 5 in normal rabbit serum. Frozen and thawed 
sensitized normal cells contained less fibroma antibody than an equal volume 
of immune serum but contrary to living immune cells, the sensitized normal 52  RESISTANCE  TO  FIBROMA  VIRUS  INFECTION 
cells did not inhibit fibroma virus any more in the living state than they did 
after freezing and  thawing. 
Attempts to Demonstrate IntraceUular Antibody: 
8 to 10 day immune peritoneal mononuclear cells, washed 3 to 5 times in saline, were 
suspended 1:2 in normal rabbit serum. One-half the cells was maintained at 4°C. while the 
other portion was frozen in a dry ice-alcohol bath (one 30 or three 10 minute freezing cycles) 
and thawed at 36°C. After centrifugation, serial dilutions of cell-free  supernatant were titrated 
against 1000 IDl0 fibroma virus. 
Very little antibody was demonstrated in either supernatant  but rarely at 
1:4 final dilution supernatant from frozen and thawed cells inhibited slightly 
more fibroma virus than supernatant from unfrozen cells. Similar results were 
obtained  with  immune  lymph  node  ceils.  In  other  experiments,  immune 
mononuclear cells were washed once in saline and once in immune serum before 
suspension at 1:2 in normal rabbit serum. Mter freezing and thawing, super- 
natant from these cells was compared with supernatant of frozen and thawed 
sensitized normal mononuclear cells.  Immune cells released no more fibroma- 
neutralizing antibody than did sensitized normal cells. 
10  day peritoneal mononuclear cells and lymph node cells were harvested 
from the same group of fibroma-infected rabbits. They were washed in saline 
and immune serum and diluted  1:2  in normal rabbit serum.  Comparison of 
cell-free  supernatants,  after  freezing  and  thawing,  revealed  that  immune 
lymph node  cells released no more neutralizing  antibody than  immune peri- 
toneal cells. 
Time of Development of Fibroma-Inhibiting  Property in Immune Cells: 
Previous experiments indicated that immune peritoneal exudates developed 
their fibroma-inhibiting property about the time that neutralizing antibody was 
first detected in the serum (6 to 7 days after fibroma infection). 
To study this point more carefully, mononuclear peritoneal cells and sera were obtained 
from groups of rabbits that had been infected with fibroma virus 1, 4, and 10 days before 
harvest. The peritoneal exudative cells from each group of rabbits were suspended 1:10 in 
their respective sera and in 10 day sera and compared to the fibroma inhibition accomplished 
by the various sera alone. 
10 day immune cells brought about the usual additional decrease in the size 
of fibromas compared to the effect of 10 day immune serum alone.  Cells ob- 
tained 1 and 4 days after fibroma infection caused no demonstrable increase in 
fibroma neutralization. 
Viral Interference as a Possible Explanation  of the Fibroma-Inhibiting  Effect of 
Immune Mononuclear Cells: 
In vitro, fibroma virus survives in or perhaps multiplies in rabbit mononuclear 
cells  (11).  Following  infection  of  the  rabbit,  fibroma virus  might  therefore DAVID g.  G~.m)Eg  53 
localize and persist in the  host's  leukocytes and macrophages.  Any fibroma 
virus present in these ceils might inhibit the multiplication  of the extra fibroma 
virus added in the neutralization test. Three types of experiments were under- 
taken to check this possibility. 
(a) Mononuclear peritoneal cells were tested for the presence of fibroma virus. Cells were 
obtained 1, 4, and 10 days after standard intracutaneous fibroma infection of groups of rab- 
bits. The cells were washed twice in saline and twice in heat-inactivated normal rabbit serum. 
Finally the ceils were diluted to a final dilution of 1:20 in heat-inactivated  normal rabbit 
serum and titrated intmcutaneously  in 0.1 ml. amounts on the rabbit abdomen. 
In several experiments fibroma virus was never demonstrated in 1 or 10 day 
cells. On one occassion a very small amount of virus was detected in 4 day cells. 
(b) Normal cells were incubated in fibroma virus and then tested for their ability to inter- 
fere with the multiplication of fibroma virus subsequently added to the serum cell mixtures. 
Pools of normal mononuclear cells were incubated 1 hour at 36°C. in 10  -t or 10  -4 dilutions of 
fibroma virus. The cells were washed in saline and normal rabbit serum and finally diluted 
1 : 10 in normal rabbit serum. Another aliquot of normal cells was incubated in virus diluent, 
washed, and suspended in normal rabbit serum in the manner of virus-treated  cells. Serial 
dilutions of virus were added to a series of tubes containing the variously treated suspensions 
of normal cells and to tubes containing only normal rabbit serum. The mixtures were placed 
in an ice bath while they were injected intracutaneously in the rabbit abdomen. The volumes 
of the resulting fibromas were just as large in the presence of virus-treated  cells and virus 
diluent-treated cells as with normal rabbit serum alone. 
No  inhibition was  therefore  effected  by mononuclear cells that  contained 
demonstrable fibroma virus. 
(c) Peritoneal exudative cells (from fibroma-infected rabbits)  might contain undetectable 
amounts of virus that could cause viral interference. Therefore pools of peritoneal mono- 
nuclear cells were obtained from rabbits 1, 4, and 10  days after fibroma infection and em- 
ployed in standard neutralization  tests. 
While 10 day cells caused significant  inhibition  of fibroma lesions, 1 and 4 day 
cells, suspended in their own or 10 day immune serum, exhibited no inhibitory 
effect on fibromas. 
Specificity of the Effect of Immune Mononudear Cells: 
Mononudear peritoneal exudates were obtained from rabbits 9  to  10 days 
after infection with Semliki forest or PR8 influenza viruses. Serum from these 
rabbits inhibited 2  to  3  LD~0  logs  of  the homologous virus. However,  1:10 
suspensions of the cells in fibroma-immune serum did not cause any greater 
inhibition  of fibroma virus than did the fibroma-immune  serum alone. Acellular 
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Effect  of  Immune  Cellular  Suspensions  Obtained from  Various  Organs  and 
Viscera: 
It was of interest to investigate the effect of splenic cells on fibroma virus 
because the cellular content of the spleen closely resembles that of the mononu- 
clear peritoneal exudates. Because of the large number of reticulo-endothelial 
cells in the liver, suspensions of liver ceils were also examined. Lymph nodes 
were studied because they appeared  to contain mainly lymphocytes. Sieved 
suspensions of heart muscle and of kidney were included in tests to represent 
organs and viscera not notable for their content of leukocytes or macrophages. 
The pools of cellular suspensions and sera were obtained from a  group of 3 
rabbits infected 9 days previously with fibroma virus. In final dilutions of 1 : 20 
in immune serum, immune liver, and immune splenic cell suspensions were just 
as effective in inhibiting fibroma virus as similar dilutions of peritoneal mono- 
nuclear exudates. In other tests, immune cells from regional lymph nodes were 
very effective in inhibiting the fibroma virus. Normal lymph node cells were 
generally ineffective, but like normal exudative peritoneal cells,  they occas- 
sionally caused moderate inhibition of fibroma virus. Similarly normal spleen 
and liver cells generally exhibited no fibroma-inhibiting ability. Immune and 
normal kidney cell suspensions did not increase the neutralizing ability of the 
immune serum. Other tests indicated that both immune and normal heart cells 
were similarly ineffective. 
Effect of Immune Buffy Coats: 
It was important to determine whether immune blood leukocytes exhibited 
the same inhibitory effect for fibroma virus as did immune leukocytes and 
macrophages obtained from peritoneum, spleen, liver, and lymph node. This 
was investigated using pools of buffy coats of peripheral blood taken from rab- 
bits 9 to 12 days after infection with fibroma virus. In 5 separate tests immune 
buffy coats added to fibroma immune serum brought about the same increase 
in fibroma neutralization as did comparable amounts of immune peritoneal 
exudates. Additional studies made on the effect of normal buffy coats sensitized 
with immune serum before use indicated that these cells (like normal peritoneal 
exudative cells) could not be converted to cells having the qualities of immune 
ceils merely by incubating them for 1 hour at 36°C. in fibroma-immune serum. 
However,  in  2  of 4  tests,  sensitized normal  buffy coats  had  slightly more 
fibroma-inhibiting power than did non-sensitized normal buffy coat in immune 
serum. 
Qualitative  and Quantitative  Considerations  of the Effects  of Immune  Cells on 
Fibroma  Virus Inhibition: 
The cells  obtained from peritoneal exudates, livers, lymph nodes, spleens, 
and buffy coats were mixtures of different types. In attempting to assess  the DAVID R.  GINDER  55 
importance  of the various  cells in producing the  effect and  to determine  the 
concentration of immune cells required to produce an effect, serial 2-fold dilu- 
tions of immune cells (from the various sources) were tested. All immune cells 
and  sera  were  obtained  9  to  11  days after  infection of rabbits  with  fibroma 
virus. Table VI indicates  the results obtained.  The greatest effective dilution 
has  been  expressed  in  terms  of number  of living  white  cells  per  ram.  3 The 
results suggest that 2000 to 4000 cells/mm.  3 were necessary to bring about the 
TABLE VI 
Qualitative and Quantitative Studies of the Fibroma-lnhibiting Activity  of Immune Cells 
from Various Sources 
No. of 
tests  Source of immune cells 
Peritoneal  exudate  6  days  after 
mineral oil 
Peritoneal  exudate  3  days  after 
mineral oil 
Peritoneal  exudate  16  hrs.  after 
saline 
Liver 
Spleen 
Buffy coat 
Regional lymph nodes 
Minima] 
effective 
ells/ram 
3500-~ 
3100-~ 
2800-~ 
1750-q 
2000 
4OOO 
3700  -~ 
2000 
2800 
3100 
3000 
4600  -? 
3900-~ 
2000-? 
1800-? 
Differential count 
Poly- I r. 
mo  ho-  ~:~u,- 
nucr~e~r phocyte 
350  875 
279  806 
112  560 
245  263 
250  820 
2600  40 
2960  222 
200  800 
280  1400 
124  1116 
60  1200 
2208  2162 
1716  2106 
0  1900 
18  1692 
L~rge mononuclear 
2275 
2015 
2128 
1242 
920 
1360 
518 
1000 
1120 
1860 
1740 
230 (monocytes) 
78 (monocytes) 
I00 
90 
effect of immune cells. As far as indicating a particular cell type as responsible 
for the effect of the immune cells the data do not permit any general conclusions 
other than that the responsible cells are probably not the polymorphonuclear 
cells. 
DISCUSSION 
These experiments indicate that fibroma-immune serum containing fibroma- 
immune  leukocytes and  macrophages  neutralized  significantly more  fibroma 56  RESISTANCE TO ]~IBRO~ VIRUS INFECTION 
virus than did fibroma serum alone. The increased neutralization, accomplished 
by immune cells, did not appear to be related to simple transfer of a greater 
total amount of specific  antibody because: (a)  killed immune exudative cells 
when added to immune serum, did not increase virus inhibition and (b) frozen 
and thawed immune exudative cells  actually had significantly less fibroma- 
neutralizing capacity than an  equal volume of frozen and  thawed immune 
serum. Yet this same volume of immune cells, when living, neutralized con- 
siderably more fibroma virus than an equivalent volume of fibroma immune 
serum.  It was possible  that  the special fibroma-inhibiting effect of immune 
ceils was related to lesser amounts of preformed antibody attached to the cell 
surface or situated inside living cells  where it could be more effective than 
larger amounts of antibody located outside cells.  Exploration of these possi- 
bilities  using peritoneal  exudative ceils,  lymph node  cells,  and buffy coats 
demonstrated that normal cells, sensitized with immune serum, did not emulate 
immune cells. This was interpreted to mean that the effect of immune ceils 
was not mediated by antibody situated solely on the cell surface. Also experi- 
ments have failed to consistently demonstrate a release of antibody froth washed 
immune cells by freezing and thawing. However small quantities of intracellular 
antibody,  undetected by  the  tests  employed,  could be  present  and  signifi- 
cantly inhibit intracellular virus.  Because of the in  vitro  affinity of fibroma 
virus for leukocytes and macrophages it is necessary to consider viral inter- 
ference as an explanation for the effect of immune cells. This possibility seems 
unlikely because fibroma virus was not demonstrated in washed immune peri- 
toneal and lymph node cells  and because normal exudative cells,  incubated 
in and containing fibroma virus,  did not interfere with the development of 
fibromas. There is still another possible explanation of the inhibition of fibroma 
virus by fibroma-immune cells, namely, cellular transfer of an ability to form 
antibody  in  recipient  animals  (8).  The  reported  experimental  results  are 
generally in accord with this concept. In the present experiments, ceils were 
not effective until  7  to  9  days after infection of the  donor rabbit  whereas 
Harris et  al.  (12)  have shown that cells  transferred as early as 4  days after 
infection of the donor animal gave rise to the development of agglutinating 
antibodies. Only further work can establish whether this is a basic difference 
or whether variables, such as the amount and the antigenicity of the infecting 
agents, the relative time of appearance of neutralizing and agglutinating anti- 
bodies, and the sensitivities of the tests employed, explain the difference in 
time required for the formation of effective cells. 
Increasing dilutions of the various cell suspensions were studied in an attempt 
to assess  the relative importance of the different cell types in the process. No 
clear cut conclusions were derived from the results (Table VI) because: (a) the 
number of tests is small and the greatest effective dilution was not found in all 
cases;  (b)  the inter-relationships of the cells  classified as large mononuclear 
cells is obscure; and (c) the physiologic activities of cells of a specific type (for DAVrD R. OmT)XR  57 
example, lymphocytes) may vary according to their source as well as the me- 
chanical factors to which the cells were subjected during preparation. However, 
the relatively wide variation in the number of polymorphonuclear cells present 
at or near the greatest effective cell dilution suggests that the polymorphonu- 
clear  leukocytes were  probably  not  the  cells  responsible  for  the  fibroma- 
inhibiting effect of immune cells. 
The present experiments are concerned with the contribution that immune 
leukocytes and/or macrophages make in dvo to the resistance of the host to 
infection with fibroma virus. The fact that fibroma virus can survive at least 
4 days in immune leukocytes and macrophages in dlro (11) does not invalidate 
these in d~o findings. The conditions that exist in tissue culture experiments 
cannot be regarded as a model of the virus-immune cell-immune serum system 
as it exists in d~o. Actually the host-virus relationships in the case of the rabbit 
and fibroma virus are of special interest. OA fibroma virus multiplies and causes 
lesions only in rabbits. Metastatic lesions are noted only rarely in adult ani- 
mals so  that ordinarily virus multiplication and production of lesions occur 
only at the site of virus injection (13,  14). The marked tissue specificity and 
the localization of lesions are probably helpful in the described experiments 
inasmuch as any local inhibition of fibroma virus by immune serum and im- 
mune cells is more apt to produce a permanent effect on the size of the resulting 
fibroma lesion. In  the described  experiments the  technique of simultaneous 
injection of immune cells and virus does not represent natural/n dvo condi- 
tions. However, as in the response of the host to other virus infections, leuko- 
cytes do appear naturally in fibromas. Indeed the leukocytes are noted about 
the time that fibromas begin to regress (13,  14)  and it is possible that these 
cells do play a role in the involution of fibromas. 
As  the result of the special atfinities of fibroma virus for leukocytes and 
macrophages, the question arises whether or not the inhibitory effect of im- 
mune cells on fibroma lesions is merely an expression of the special relationship 
of leukocytes and macrophages to fibroma. The experiments were only  per- 
formed with fibroma virus; therefore, only further work can resolve the question 
of whether the described effect of immune leukocytes and macrophages obtains 
in other virus-immune serum systems. However, the characteristic intracellular 
localization  of  virus  suggests  that  it  is  possible  that  sufficiently  sensitive 
systems could demonstrate similar inhibitory effects of immune cells on other 
viruses. 
SUMMARY 
Leukocytes  and macrophages, obtained from fibroma-immune rabbits  and 
added to immune serum-fibroma virus mixtures, significantly  increased the 
neutralization of fibroma virus as compared with immune serum alone.  Im- 
mune cell  suspensions  from peritoneal  exudates, regional  lymph nodes, buffy 
coats, spleen, and liver were all effective in inhibiting fibroma virus. Approxi- 58  RESISTANCE  TO  FIBROMA  VIRUS  INFECTION 
mately 2000 to 4000 immune cells/ram? were necessary to cause an effect but 
no particular cell type could be implicated as responsible for the inhibition of 
fibroma  virus.  Normal  cells  did  not  consistently  and  significantly inhibit 
fibroma virus and cells  from rabbits  immunized with other viruses did not 
inhibit fibroma virus. 
Studies of the mechanism of action of the immune cells revealed: (a)  that 
living cells were essential; (b) that normal cells, sensitized with immune serum, 
did not simulate the effects of immune cells; (c) that immune cells contained 
less  preformed neutralizing antibody than an equivalent volume of immune 
serum, and  (d)  that inhibition of fibroma lesions was not the result of viral 
interference. 
It is suggested that the fibroma-neutralizing effect of immune cells is related 
to intracellularly placed antibody or to cellular transfer of an ability to form 
specific antibody in recipient animals. 
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EXPLANATION  OF PLATE  1 
FIG. I. Fibromas  in the vertical row on the right resulted from the injection  of 
mixtures of fibroma virus dilutions  and fibroma immune  serum. In the vertical  row 
to the left  are fibromas of lesser  volume  produced  by injecting mixtures containing 
fibroma immune cells  in addition  to the same  fibroma virus dilutions and fibroma 
immune serum. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  101  PLATE  1 
FIG.  1 
(Ginder:  Resistance to fibroma virus infection) 